Literature DB >> 34021480

Image-guided percutaneous cholecystostomy: a comprehensive review.

Shayeri Roy Choudhury1, Pankaj Gupta2, Shikha Garg1, Naveen Kalra1, Mandeep Kang1, Manavjit Singh Sandhu1.   

Abstract

Acute cholecystitis (AC) is a common emergency condition with severity ranging from mild to severe. Gallstones and critical illnesses are the common predisposing factors. Mild AC is primarily managed with medical therapy and early cholecystectomy. Moderate and severe AC require individualized treatment with a preference for early cholecystectomy. However, cholecystectomy may not always be feasible due to co-morbidities. Hence, this group of patients needs minimally invasive methods to drain the gallbladder (GB). Percutaneous cholecystostomy (PC) is the image-guided drainage of GB in the setting of moderate to severe AC. There are different approaches to PC. The technical aspects, success, and complications of PC as well as management of cholecystostomy catheter after the patient recovers from the acute episode should be thoroughly understood by the interventional radiologist. We present an extensive up-to-date review of the essential aspects of PC including indications, contraindications, techniques, and outcomes, including complications and success rates.
© 2021. Royal Academy of Medicine in Ireland.

Entities:  

Keywords:  Acute cholecystitis; Image-guided; Percutaneous cholecystostomy

Mesh:

Year:  2021        PMID: 34021480     DOI: 10.1007/s11845-021-02655-7

Source DB:  PubMed          Journal:  Ir J Med Sci        ISSN: 0021-1265            Impact factor:   1.568


  52 in total

Review 1.  [The intensive care gallbladder as shock organ: symptoms and therapy].

Authors:  C Rimkus; J C Kalff
Journal:  Chirurg       Date:  2013-03       Impact factor: 0.955

2.  Is percutaneous cholecystostomy the optimal treatment for acute cholecystitis in the very elderly?

Authors:  M Sugiyama; M Tokuhara; Y Atomi
Journal:  World J Surg       Date:  1998-05       Impact factor: 3.352

3.  Clinical characteristics of patients with newly developed acute cholecystitis after admission to the intensive care unit.

Authors:  Soo Jung Kim; Seok Jeong Lee; Su Hwan Lee; Jin Hwa Lee; Jung Hyun Chang; Yon Ju Ryu
Journal:  Aust Crit Care       Date:  2018-04-19       Impact factor: 2.737

4.  Acute cholecystitis: a complication in severely injured intensive care patients.

Authors:  J Raunest; M Imhof; U Rauen; C Ohmann; K P Thon; K F Bürrig
Journal:  J Trauma       Date:  1992-04

5.  Risk factors for perioperative complications in patients undergoing laparoscopic cholecystectomy: analysis of 22,953 consecutive cases from the Swiss Association of Laparoscopic and Thoracoscopic Surgery database.

Authors:  Urs F Giger; Jean-Marie Michel; Isabelle Opitz; Devdas Th Inderbitzin; Thomas Kocher; Lukas Krähenbühl
Journal:  J Am Coll Surg       Date:  2006-09-20       Impact factor: 6.113

6.  Percutaneous cholecystostomy.

Authors:  Okan Akhan; Devrim Akinci; Mustafa N Ozmen
Journal:  Eur J Radiol       Date:  2002-09       Impact factor: 3.528

7.  Acute cholecystitis in high-risk patients: percutaneous cholecystostomy vs conservative treatment.

Authors:  Adam A Hatzidakis; Panos Prassopoulos; Ioannis Petinarakis; Elias Sanidas; Emmanuel Chrysos; Georgios Chalkiadakis; Dimitrios Tsiftsis; Nicholas C Gourtsoyiannis
Journal:  Eur Radiol       Date:  2002-02-21       Impact factor: 5.315

8.  Ultrasonically guided percutaneous catheter drainage for gallbladder empyema.

Authors:  R W Radder
Journal:  Diagn Imaging       Date:  1980

9.  Clinical course of percutaneous cholecystostomies: A cross-sectional study.

Authors:  Sadettin Er; Hüseyin Berkem; Sabri Özden; Birkan Birben; Erdinç Çetinkaya; Mesut Tez; Bülent Cavit Yüksel
Journal:  World J Clin Cases       Date:  2020-03-26       Impact factor: 1.337

10.  Percutaneous Cholecystostomy for Severe Acute Cholecystitis: A Useful Procedure in High-Risk Patients for Surgery.

Authors:  S Aroori; C Mangan; L Reza; N Gafoor
Journal:  Scand J Surg       Date:  2018-09-18       Impact factor: 2.360

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.